07:00 , Mar 19, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: MicroRNA-455-5p (miR-455-5p); adenosine deaminase RNA-specific (ADAR; ADAR1)

Cancer INDICATION: Melanoma Cell culture and mouse studies suggest inhibiting wild-type miR-455-5p or stimulating ADAR1 activity could help prevent metastatic melanoma. In normal cells, the RNA-editing enzyme ADAR1 converts adenosine to inosine at two positions in miR-455-5p,...